“For Tomorrow 2015”
Mid-term Management Initiative
(FY2011-2015) progress and outlook

from the beginning

“For Tomorrow 2015" Mid-term Management Initiative (FY2011-2015) progress and outlook

• Contents

1. Outline of “For Tomorrow 2015"

• Positioning of“For Tomorrow 2015"

• Basis for action

• Basic strategy

• Business strategy (1) Development based on world leadership

• Business strategy (2) Creation of new social value

• Business strategy (2)Creation of new value through “For Tomorrow"projects

• Vision for the Asahi Kasei Group

2. Progress to date

• Action taken and decisions made in FY 2011-1

• Action taken and decisions made in FY 2011-2

• World-leading businesses Acrylonitrile* (AN)

• Health care-related Teribone osteoporosis drug

• World-leading businesses Environment/energy-related Hipore LIB* separator

• Residential living-related Demonstration house“HH 2015"

• Progress of the “For Tomorrow"projects

3. Forthcoming steps

• Forthcoming steps-1

• Forthcoming steps-2

• Development of world-leading businesses

• Creation of new value for society: Environment/energy-related field

• Creation of new value for society: Residential living-related field

• Creation of new value for society: Health care-related field

• Performance of global-leading businesses and businesses creating new value for society

• Quantitative indexes of achievement of Group Mission

• Progress on investment

• Vision for the Asahi Kasei Group(No change from the initial plan)

4.Expansion of Health Care business with acquisition of ZOLL Medical Corporation

• Critical Care: a core business field in our mid-term initiative

• Motivations for advancement into Critical Care

• Product portfolio based on“Chain of Survival"

• P70 LifeVest growth potential (FY11 sales $111 mllion)

• P71 High growth potential for Thermogard (FY11 sales $26 million)

@P33

• Combining strengths

• Desired strategic initiatives (1)

• Desired strategic initiatives (2)

• Key concepts in Health Care for Tomorrow

• Scaling up Health Care to match Chemicals & Homes

• Creating for Tomorrow

Reference(slides only below)

• Sales and operating income by segment

• History of business portfolio transformation, change in sales composition

• Net sales, operating income, and D/E ratio

• New business development strategy in mid-term management initiative

• Chemicals & Fibers Acrylonitrile

• Chemicals & Fibers Synthetic rubber: solution-polymerized SBR(S-SBR)

• Chemicals & Fibers Microza hollow-fiber membrane for filtration

• Chemicals & Fibers Business portfolio of Chemicals

• Chemicals & Fibers Main products of chemicals & derivative products in Chemicals

• Chemicals & Fibers Specialty products in Chemicals

• Chemicals & Fibers Main products in Fibers

• Homes & Construction Materials Financial performance and actions in Homes

• Homes & Construction Materials“Long Life Home" strategy for Hebel Haus

• Homes & Construction Materials Sales and order trends in Homes

• Main products in Construction Materials

• Health Care Pharmaceuticals (1)

• Health Care Pharmaceuticals (2)

• Health Care Pharmaceuticals (3)

• Health Care Medical devices (1) Artificial kidneys

• Health Care Medical devices (2) Artificial kidneys

• Health Care Medical devices (3) Therapeutic apheresis devices, leukocyte reduction filters, and virus removal filters

• Health Care Medical devices (4) Planova virus removal filters

• Electronics Electronic materials (1) Hipore lithium-ion battery separator

• Electronics Electronic materials (2)

• Electronics Electronic devices (1) Analog/digital mixed-signal LSIs

• Electronics Electronic devices (2)

• Electronics Electronic products

• Critical Care ZOLL Corporate Profile

• Defibrillator business has strong reputation in the US

• LifeVest growth potential (FY11 sales $111 mllion)

• High growth potential for Thermogard (FY11 sales $26 million)

• (2) Creation of new value for society Recent actions and advances (1)

• (2) Creation of new value for society Recent actions and advances (2)

Q&A session